Literature DB >> 29128018

Update in Chronic Lung Allograft Dysfunction.

Rupal J Shah1, Joshua M Diamond2.   

Abstract

Chronic lung allograft dysfunction (CLAD) is the major limitation to posttransplant survival. This review highlights the evolving definition of CLAD, risk factors, treatment, and expected outcomes after the development of CLAD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bronchiolitis obliterans syndrome; Chronic lung allograft dysfunction; Diagnosis; Risk factors; Treatment

Mesh：

Year:  2017        PMID： 29128018     DOI： 10.1016/j.ccm.2017.07.009

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  3 in total

1.  Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Guang-Shing Cheng; Katherine E Selwa; Charles Hatt; Sundaresh Ram; Aleksa B Fortuna; Margaret Guerriero; Ben Himelhoch; Daniel McAree; Timothy C Hoffman; Joseph Brisson; Ryan Nazareno; Kiernan Bloye; Timothy D Johnson; Mats Remberger; Jonas Mattsson; Dharshan Vummidi; Ella E Kazerooni; Vibha N Lama; Stefanie Galban; Michael Boeckh; Gregory A Yanik; Craig J Galban
Journal:  Am J Transplant       Date:  2020-03-06       Impact factor: 8.086

Review 2.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

3.  Host-Pathogen Interactions after Lung Transplant: Are Cystic Fibrosis Patients Unique?

Authors:  Eric D Morrell; Erika D Lease
Journal:  Cell Rep Med       Date:  2020-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.